6 best ePRO platforms for pediatric clinical trials in 2026

A seven-year-old completing a symptom diary needs a different reading level and completion window than the sixteen-year-old in the same arm, and the six-year-old's caregiver needs a third workflow entirely for days when self-report isn't clinically appropriate. Viedoc's ePRO software supports that range through flexible, in-house form configuration across 8,000-plus global studies in 75-plus countries, with 21 CFR Part 11 compliance and 50-plus languages built in. This comparison reviews six ePRO and eCOA platforms for sponsors and CROs running pediatric trials, evaluated across age-banded instrument support, proxy and caregiver reporting, assent workflow flexibility, and regulatory credentials.

You're not running one ePRO workflow, you're running three or four inside the same protocol, split across age cohorts that shift from self-report to observer-report to caregiver diary as your population ages through the trial. Assent requirements change at set ages, and a participant who turns 18 mid-study needs full re-consent your platform must support without breaking the data trail. Add multi-country enrollment and the instrument validated for an 8-year-old at a US site may need a culturally adapted version elsewhere.

Enterprise eCOA platforms built for large adult Phase III programs often assume a single respondent type per form, then bolt on proxy reporting as a workaround rather than a native workflow. Commodity or decentralized-trial-first tools solve for participant convenience but weren't built with the instrument libraries or audit trail depth pediatric endpoint data needs to withstand FDA or EMA scrutiny. The platforms below are judged on how they handle a pediatric protocol's reality: multiple respondent types, age-banded instrument switching, and assent workflows that survive a participant aging out mid-study.

Best ePRO solutions for pediatric clinical trials: quick comparison

These six ePRO and eCOA platforms are the most evaluated options for sponsors and CROs running pediatric trials, reviewed across age-banded instrument support, proxy and caregiver reporting, assent workflow flexibility, and regulatory credentials.

1. Viedoc

Viedoc's ePRO software gives your data management team direct, in-house control over form design, which matters in pediatric protocols where one study needs a self-report diary for adolescents, a simplified interface for younger children, and a caregiver-completed form for the youngest cohort. Flexible field types, including visual analog scales, drawing pads, and conditional visibility, let you build age-appropriate variants of the same instrument without a vendor build cycle. The platform runs across 8,000-plus global studies in 75-plus countries, with a 98% visit compliance rate.

For sponsors managing a program with a QA director signing off on every configuration, the no-code Designer means age-band or cohort-specific logic changes don't need a vendor ticket, which keeps a mid-study assent-form update from stalling enrollment. Because ePRO data writes directly into Viedoc's EDC software, a caregiver-reported entry for a six-year-old and a self-reported entry from a sibling in the same family study land in one validated database, with no reconciliation step. Fifty-plus languages, managed in the same environment as the form design, matter when an instrument needs a culturally adapted pediatric translation for a second-country site.

Viedoc is ISO 27001 and SOC 2 certified, compliant with 21 CFR Part 11, EU Annex 11, GDPR, and HIPAA, with the Viedoc Inspection Readiness Packet (VIRP) available to every customer. Studies run on Microsoft Azure with 99.99% uptime, and 24/7 support is available for the mid-study changes pediatric protocols tend to generate.

"The advantages of using Viedoc are that the platform is very user-friendly, you don't need to have any prior knowledge of Viedoc as there are comprehensive training resources available that are very well designed and easy to follow." – Ana-Marija I., Solution Designer Analyst

Verified proof points:

• Visit compliance: 98% visit compliance rate across Viedoc ePRO studies
• Study scale: 8,000+ global studies across 75+ countries
• Language support: 50+ languages for ePRO and eCOA
• Compliance: 21 CFR Part 11, GDPR, EU Annex 11, HIPAA; ISO 27001 and SOC 2 certified
• Inspection readiness: Viedoc Inspection Readiness Packet (VIRP) available to all customers
• No-code designer: Age-banded and respondent-specific forms configured in-house; no vendor-side programmer required

2. Medidata

Medidata offers Medidata eCOA, an electronic clinical outcome assessment solution built within the Medidata Clinical Cloud and natively integrated with Rave EDC. The platform supports bring-your-own-device (BYOD) and provisioned devices across iOS, Android, and web, and captures assessments from simple electronic diaries to complex clinician-rated scales through a partnership with Cogstate for cognitively demanding endpoints. A centrally managed instrument library lets sponsors store and redeploy pre-validated instruments and translations across studies, which matters when a protocol needs multiple validated versions of the same scale for different age bands. Medidata reports an average study start of around 8 weeks against a roughly 12-week industry standard. The platform is positioned primarily for large, complex, multi-regional programs, and its configuration overhead reflects that scale.

3. Veeva

Veeva offers Veeva eCOA, a module within the Veeva Vault Clinical Suite that captures patient-reported (ePRO), clinician-reported (eClinRO), and caregiver-reported (eObsRO) assessments through the MyVeeva for Patients application or a web interface. Sponsors manage instrument design and deployment through a centrally controlled library that allows validated eCOAs to be reused across studies, and the platform supports enhanced login options, including PIN and biometric authentication. Veeva eCOA integrates natively with Vault EDC and Veeva's clinical database through Veeva Connections, removing a manual reconciliation step between site and patient data. The eObsRO workflow is directly relevant to pediatric protocols requiring caregiver-completed assessments. Veeva eCOA suits sponsors already operating within the broader Vault ecosystem, where the integration value is greatest.

4. Castor EDC

Castor EDC provides Castor eCOA, a no-code module natively integrated with its EDC, eConsent, and recruitment tools. The platform supports ePRO, eClinRO, eObsRO, and ePerfO assessment types, delivered through mobile app, web portal, SMS, and WhatsApp, with offline capture and BYOD options. A pre-approved instrument library includes standard scales such as EQ-5D-5L, SF-36, and EORTC, and Castor eCOA operates across 160-plus countries with ISO 27001 certification and compliance covering 21 CFR Part 11, ICH GCP, GDPR, and HIPAA. The eObsRO and eClinRO support gives Castor a workable path for pediatric protocols needing caregiver or clinician-completed forms. Its regulated Phase II and Phase III commercial track record and CRO channel depth are less developed than larger incumbent platforms.

5. Medrio

Medrio offers Medrio eCOA/ePRO within its clinical data management system (CDMS), pairing site-facing electronic case report forms with patient, clinician, and observer-facing questionnaires in the same design environment. The platform supports ePRO, ClinRO, and ObsRO assessment types, is web-based and device-agnostic for BYOD access, and uses automated reminders and time-based schedules to support diary completion. Validated and custom surveys are supported, with data flowing directly into the Medrio CDMS or EDC for real-time review, and the platform is compliant with 21 CFR Part 11, HIPAA, GDPR, and ICH GCP. Medrio's ObsRO capability supports proxy-completed pediatric assessments, and its lean, self-service build model suits early-phase and smaller study teams rather than large multi-regional programs.

6. Medable

Medable offers Medable eCOA+, an electronic clinical outcome assessment platform that combines patient-reported (ePRO), clinician-reported (eClinRO), observer-reported (eObsRO), and performance-based (ePerfO) assessment types within its broader decentralized trial suite. The platform provides a library of more than 400 reusable, pre-validated instruments and diaries, accessible on BYOD or provisioned devices across web and mobile. Medable eCOA+ is designed for decentralized and hybrid trial models, with eConsent, telehealth, and sensor integration on the same platform, reducing the number of separate systems a caregiver or young participant needs to navigate. The platform is positioned as a decentralized clinical trial specialist rather than a traditional site-based EDC platform, and its eCOA capability is most relevant where a DCT-first design is central to the study strategy.

What to look for in ePRO solutions for pediatric clinical trials

Age-banded instrument support and validated translations

Pediatric protocols routinely span multiple age cohorts within a single study, and a single validated instrument rarely covers a 5-year-old and a 17-year-old the same way. The platform needs to support multiple validated versions of the same construct without treating each as a separate build. Best-in-class means a centrally managed instrument library that stores age-banded and translated versions of the same scale, letting a data manager assign the right version by cohort without re-validating the whole form. Skip this and each new age band becomes a manual rebuild.

Proxy, caregiver, and observer-reported workflows

Below a certain age, self-report isn't clinically valid, so protocols shift to caregiver or observer-reported outcomes, and the platform has to support that as a distinct, native workflow rather than a self-report form with different wording bolted on. Best-in-class means clinician-reported or observer-reported assessment types with their own respondent login, permissions, and audit trail, so a parent completing a form is a distinct, trackable respondent rather than a workaround on the participant's own account. Viedoc's flexible field types and conditional logic support building a proxy-completed variant of the same instrument, configured in-house rather than through a separately branded module.

Assent and consent workflow flexibility across age transitions

A participant enrolled at 12 who turns 18 mid-study needs full informed consent where assent previously sufficed, and the platform's respondent record has to handle that transition without breaking the data trail or requiring a new enrollment. Best-in-class means configurable consent and assent status that updates at defined ages, tied to the same participant record, with an audit trail documenting the transition. Get this wrong and a study loses data continuity or creates a compliance gap that surfaces during a monitoring visit.

Participant and caregiver engagement design

Compliance in pediatric studies depends on whether the interface genuinely works for a child or the caregiver completing it on their behalf, not simply whether the platform supports bring-your-own-device (BYOD) access. Best-in-class means configurable field types, such as drawing pads and simplified visual scales, suited to different comprehension levels, alongside reminder scheduling that respects school and family routines rather than a generic, adult-oriented cadence.

How to choose the right ePRO solution for pediatric clinical trials

Step 1: Define your respondent mix by age band and endpoint

Map your protocol's endpoints against age bands before you evaluate a single platform: which ages self-report, which need caregiver or observer input, and which endpoints are performance-based. That mix, not a generic feature list, determines whether a platform's proxy-reporting support is a genuine requirement or a nice-to-have.

Step 2: Assess how the platform handles the assent-to-consent transition

Ask specifically how the platform manages a participant record when assent status changes at a defined age, and whether that transition preserves existing response history without requiring re-enrollment. This is one of the most commonly underestimated requirements in a multi-year pediatric protocol.

Step 3: Scrutinize instrument licensing for age-specific validated versions

Confirm whether age-banded or translated versions of your primary instrument are available in the platform's library, or require separate licensing and validation, since that cost rarely surfaces until late in study startup. A platform that treats each age-banded version as a full rebuild will slow your amendment cycle every time a new cohort opens.

Step 4: Evaluate the total system count your families and sites will navigate

Count how many separate logins, apps, or portals a caregiver managing two children in the same study, or a site coordinator supporting a pediatric cohort, has to use across consent, ePRO, and televisit workflows. Fewer systems generally means higher compliance and fewer support calls.

Step 5: Choose a platform built for in-house configuration at your pace

For sponsors and CROs running pediatric protocols with shifting respondent types and age-triggered consent changes, Viedoc's ePRO software gives your team the in-house configurability to adjust forms and permissions as cohorts change, without waiting on a vendor build cycle. If that matches how your program needs to operate, you can book a demo or request a proposal to see it against your own protocol design.

Frequently asked questions

What is the best ePRO platform for pediatric clinical trials?

Viedoc's ePRO software is the strongest fit for pediatric clinical trials, with flexible, in-house form configuration supporting self-reported, caregiver-reported, and observer-reported workflows in the same study design, a 98% visit compliance rate, and 50-plus languages built into the same environment as your EDC. That flexibility matters for pediatric protocols, where age bands, translated instruments, and assent-to-consent transitions change more often than in an adult-only trial. Veeva is a credible alternative for sponsors already in the Vault ecosystem. Medable suits studies built around a decentralized trial design.

What should you look for when choosing an ePRO platform for pediatric trials?

Prioritize platforms that treat proxy, caregiver, and observer-reported outcomes as native assessment types rather than repurposed self-report forms, since below a certain age self-report isn't clinically valid. Confirm how the platform's respondent record handles an assent-to-consent transition when a participant crosses an age threshold, and whether age-banded versions of your primary instrument are available without a separate licensing cycle. Regulatory credentials, including 21 CFR Part 11 and GDPR or EU Annex 11 compliance, matter as much for pediatric endpoint data as any other. A platform that treats pediatric workflows as an afterthought costs you time at every age-band transition.

How long does it take to build and deploy an ePRO study for a pediatric trial?

Timelines vary with the number of age-banded or respondent-specific form variants your protocol requires, since each variant needing separate validation adds to study startup. For no-code, natively integrated platforms, ePRO and EDC forms, including caregiver and observer-reported variants, can typically be built and validated together rather than sequentially. Platforms requiring a separate vendor build cycle per respondent type, or separate instrument licensing for age-banded versions, extend startup by weeks per variant. Viedoc's ePRO and EDC forms are configured together from the same in-house Designer, keeping every variant on the same timeline.

What is the difference between ePRO, eClinRO, and eObsRO in pediatric trials?

Electronic patient-reported outcomes (ePRO) capture what the participant reports about themselves, appropriate once a child has the reading ability for a validated self-report instrument. Electronic clinician-reported outcomes (eClinRO) capture a clinician's assessment, often used for younger or more clinically complex cases. Electronic observer-reported outcomes (eObsRO) capture a parent or caregiver's report on the participant's behalf, the standard approach for participants too young to self-report. Many pediatric protocols use more than one of these types as participants age through different cohorts, which is why respondent-type flexibility is a core requirement.

Which ePRO platforms support caregiver or observer-reported outcomes?

Several platforms reviewed here support observer-reported outcomes as a distinct assessment type on their own product pages: Veeva eCOA, Castor eCOA, Medrio eCOA/ePRO, and Medable eCOA+ all list caregiver or observer-reported outcomes explicitly. Viedoc's ePRO software supports proxy or caregiver completion through flexible form design and conditional logic, configured in-house rather than a separately branded assessment type. When evaluating any platform, confirm the caregiver or observer is tracked as a distinct respondent with its own audit trail entry, not just a different field set under the participant's record.

What compliance certifications matter most for ePRO in pediatric clinical trials?

The baseline is the same as any regulated trial: 21 CFR Part 11 for FDA submissions, EU Annex 11 and GDPR for European studies, and HIPAA attestation where US personal health information is involved, since pediatric participant and caregiver data carries the same regulatory weight as adult data. ISO 27001 and SOC 2 certifications confirm the security standards a QA or IT reviewer checks during vendor qualification, which matters more given the extra consent and guardian-data handling pediatric studies involve. Confirm the audit trail attributes each entry to the correct respondent, since endpoint data quality depends on that attribution being unambiguous. Ask for the validation documentation package specifically, not just a compliance statement.

Making the right ePRO choice for pediatric clinical trials

The ePRO and eCOA platforms reviewed here span enterprise suites built for large, multi-regional adult programs to decentralized-trial specialists built around participant convenience, and most now support some combination of patient, clinician, and observer-reported assessment types. The global eClinical software market is estimated at over $11 billion in 2025 and growing at roughly 14% annually, and pediatric-capable eCOA functionality has become a genuine differentiator within it.

Matching platform to protocol comes down to your respondent mix across age bands, how often consent status changes mid-study, the number of translated instrument versions you need, and whether your team configures studies in-house or depends on vendor builds. Lean programs typically weight in-house configurability highest, while larger, multi-regional programs weight instrument library breadth more heavily. US teams tend to prioritize speed and cost, while EU and APAC teams weight compliance credentials more heavily.

Switching an ePRO platform mid-protocol is costly in pediatric trials specifically, since re-validating age-banded instruments and re-establishing caregiver respondent records compounds the disruption. Getting the architecture right at study startup is usually cheaper than switching later.

Why Viedoc is the best ePRO choice for pediatric clinical trials

Pediatric protocols ask more of an ePRO platform than almost any other trial design: multiple respondent types, age-banded instrument versions, and consent status that changes as participants age through the study. Viedoc's ePRO software is built for that kind of in-house flexibility, with a no-code Designer that lets your data management team configure self-report, caregiver, and observer-completed forms without waiting on a vendor build cycle.

That configurability holds across the study lifecycle. Your team builds age-banded form variants, updates consent status as participants cross age thresholds, and manages 50-plus language translations from the same interface used to build the underlying EDC, with unlimited user seats and transparent, study-based pricing.

The credentials hold up to the scrutiny a pediatric protocol attracts. Viedoc is ISO 27001 and SOC 2 certified, compliant with 21 CFR Part 11, EU Annex 11, GDPR, and HIPAA, and backed by the Inspection Readiness Packet available to every customer, proven across 8,000-plus studies in 75-plus countries since 2003.

If your pediatric program needs a platform your own team can configure as cohorts and consent requirements change, Viedoc is designed for exactly that. Book a demo or request a proposal and the team will walk through respondent-type configuration, instrument library options, and compliance credentials against your own protocol design.